|
|
|
42
|
59633
|
GALVUSMET 1G|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
C
|
27.18
|
0.49
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59637
|
KOMBIGLYZE 1G | 5MG TAB (AZN/COL) METFORMIN | SAXAGLIPTIN
|
METFORMIN|SAXAGLIPTIN
|
KOMBIGLYZE
|
28'S
|
C
|
51.65
|
1.84
|
TABLET
|
0
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59637
|
KOMBIGLYZE 1G|5MG TAB (AZN) METFORMIN|SAXAGLIPTIN (C)
|
METFORMIN|SAXAGLIPTIN
|
KOMBIGLYZE
|
28'S
|
C
|
54.23
|
1.9368
|
TAB
|
0
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
59637
|
KOMBIGLYZE 1G|5MG TAB (AZN) METFORMIN|SAXAGLIPTIN
|
METFORMIN|SAXAGLIPTIN
|
KOMBIGLYZE
|
28'S
|
C
|
56.95
|
2.03
|
TAB
|
0
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59639
|
JANUMET XR 1G | 50MG TAB (MSD/STO) METFORMIN XR | SITAGLIPTIN
|
METFORMIN XR|SITAGLIPTIN
|
JANUMET XR
|
60'S
|
C
|
93.89
|
1.56
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
5963C
|
JANUMET XR 1G | 100MG TAB (MSD/STO) METFORMIN XR | SITAGLIPTIN
|
METFORMIN XR|SITAGLIPTIN
|
JANUMET XR
|
30'S
|
C
|
93.89
|
3.13
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
5963E
|
JANUMET 1G|100MG XR TAB (MSD) METFORMIN XR|SITAGLIPTIN (C)
|
METFORMIN XR|SITAGLIPTIN
|
JANUMET
|
28'S
|
C
|
93.89
|
3.3532
|
TABXR
|
0
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
41
|
5963N
|
JANUMET 1G|50MG XR TAB (MSD) METFORMIN XR|SITAGLIPTIN (C)
|
METFORMIN XR|SITAGLIPTIN
|
JANUMET
|
56'S
|
C
|
93.89
|
1.6766
|
TABXR
|
0
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5963Q
|
TRAJENTAMET 2.5MG|1000MG TAB (BOE) LINAGLIPTIN|METFORMIN
|
LINAGLIPTIN|METFORMIN
|
TRAJENTAMET
|
60'S
|
C
|
114.66
|
1.91
|
TAB
|
0
|
BLIS
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5963S
|
METFOR SITA EZE 1G|50MG TAB (INF) METFORMIN|SITAGLIPTIN
|
METFORMIN|SITAGLIPTIN
|
METFOR SITA EZE
|
10X10
|
C
|
18.29
|
0.18
|
TAB
|
0
|
BLIS
|
INF
|
INFOCUS REMEDIES PVT
|
RXP
|
RX PRO INC
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5963U
|
VILDALION-M 1G|50MG TAB (STL) METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
VILDALION-M
|
60'S
|
B
|
5.74
|
0.10
|
TAB
|
60
|
BLIS
|
STL
|
STALLION LABORATORIES
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
60013
|
FERASIRO 125MG TAB (MSN/ATB)
|
DEFERASIROX
|
FERASIRO
|
28'S
|
C
|
200.07
|
7.15
|
TABLET
|
0
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
41
|
60014
|
APO-DEFERASIROX 125MG TAB (APO) (C)
|
DEFERASIROX
|
DEFERASIROX
|
28'S
|
C
|
109.33
|
3.9047
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
42
|
60022
|
DESIROX 250MG TAB (CIP) DEFERASIRO (C)
|
DEFERASIROX
|
DESIROX
|
30'S
|
C
|
52.95
|
1.77
|
TAB
|
0
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2026-04-01
|
|
|
ORAL
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
40
|
60025
|
FERASIRO 250MG TAB (MSN/ATB)
|
DEFERASIROX
|
FERASIRO
|
28'S
|
C
|
400.41
|
14.30
|
TABLET
|
0
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
41
|
60027
|
APO-DEFERASIROX 250MG TAB (APO)
|
DEFERASIROX
|
APO-DEFERASIROX
|
30'S
|
C
|
218.8
|
7.2933
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
42
|
60032
|
DEFERASIROX 500MG TAB (CIP) (C)
|
DEFERASIROX
|
DEFERASIROX
|
30'S
|
C
|
89.24
|
2.97
|
TAB
|
0
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2026-04-01
|
|
|
ORAL
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
40
|
60035
|
FERASIRO 500MG TAB (MSN/ATB)
|
DEFERASIROX
|
FERASIRO
|
28'S
|
C
|
801.09
|
28.61
|
TABLET
|
0
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
41
|
60036
|
APO-DEFERASIROX 500MG TAB (APO) (C)
|
DEFERASIROX
|
DEFERASIROX
|
30'S
|
C
|
437.73
|
14.5911
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
40
|
6031P
|
GYNOLAX 50MG TAB (ABB/PHA) CLOMIPHENE
|
CLOMIPHENE
|
GYNOLAX
|
10'S
|
C
|
5.74
|
0.57
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681612
|
ESTROGEN AGONIST-ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|